English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

On the basis of the in vitro stability of factor VIII concentrate at room temperature, continuous intravenous infusion of the remedey could be utilized as a hemostatic management for a major surgey in hemophilia A. One hour prior to the amputation of the left femule of the patient, 55u/kg of Hemofil H® as a bolus pretreatment and thereafter continuous infusion by quantitative pump with 2.7u/kg/hr of Hemofil H® for 3 days, 2.2u/kg/hr for next 5 days, 1.6u/kg/hr for the third period of 6 days, and 0.8u/kg/hr for last period of 4 days were followed. Consequently it was able to stabilize the hemostatic level of plasma VIII:C with the preparation, of which amount was less than that of previous cases with major surgical operations managed by bolus infusions of the similar preparation.Thus, this continuous infusion method applied on major surgery of hemophiliacs might be recommended as a thrapeutic way being safer and more economic than the conventional method, because no excess amount of factor VIII concentrate are infused.

The replacement therapy with quantitative infusion of fVIII concentrate and its merit on plasma level and total dose.